Saturday, 31 October 2026European Markets

IEX GROUP NV Stock 11.43% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with IEX GROUP NV (IEX.AS) rising 11.43% to €1.95 on Monday, following the last session's upward trend. AEX-Index fell 0.03% to €786.82, following the last session's downward trend on what was a somewhat bearish trend exchanging session today.

IEX GROUP NV's last close was €1.95, 2.5% below its 52-week high of €2.00.

About IEX GROUP NV

IEX Group N.V., through its subsidiaries, operates financial websites in the Netherlands and Belgium. It operates Beurs.nl, Belegger.nl, Beleggen.nl, DeBeurs.nl, Beursonline.nl, Participaties.nl, Beursgorilla.nl, Tostrams.nl and Guruwatch websites. The company also provides investment information services. In addition, the company offers IEX Expert and IEX Profs magazine for various investors; and organizes various events for private individuals and professionals. IEX Group N.V. was founded in 1999 and is based in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, IEX GROUP NV has a trailing twelve months EPS of €0.25.

PE Ratio

IEX GROUP NV has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing €7.8 for every euro of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 5M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IEX GROUP NV's stock is considered to be oversold (<=20).

Volatility

IEX GROUP NV's last week, last month's, and last quarter's current intraday variation average was 0.42%, 0.78%, and 6.38%.

IEX GROUP NV's highest amplitude of average volatility was 5.56% (last week), 6.08% (last month), and 6.38% (last quarter).

Moving Average

IEX GROUP NV's worth is way higher than its 50-day moving average of €1.76 and above its 200-day moving average of €1.79.

More news about IEX GROUP NV (IEX.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com